Company news
Niox Group Plc (LSE:NIOX) news
Niox Group Plc news releases on 6ix. Latest, Dec 11, 2018: Option exercised for Tudorza from AstraZeneca
Press releases — page 3
Option exercised for Tudorza from AstraZeneca
December 11, 2018
Posting of Shareholder Circular
December 10, 2018
Interim Results for Six Months Ended 30 June 2018
September 27, 2018
Notice of Interim Results and Broker Appointment
September 7, 2018
Director Declaration
August 16, 2018
Regulatory Application
August 13, 2018
Issue of Equity and Total Voting Rights
July 18, 2018
Publication of Circular
June 27, 2018
US Filing of Duaklir NDA & Tudorza Supplement NDA
June 1, 2018
Positive Data Presented at 2018 ATS Conference
May 22, 2018
Annual Financial Report and Notice of AGM
April 27, 2018
Issue of Equity - AstraZeneca
April 24, 2018
Receives Innovative Tech Contract from Vizient
February 8, 2018
Block Listing Six Monthly Return
January 17, 2018
TR-1: Notification of major holdings
January 8, 2018
Notification of Major Holdings
December 19, 2017
Tudorza® Meets Primary Endpoints in ASCENT Study
December 4, 2017
Circassia Welcomes New NICEAsthma Guidelines
November 29, 2017
Interim results six months ended 30 June 2017
September 27, 2017
European Launch of NIOX VERO® Nasal Mode
September 12, 2017
Primary Endpoints Met in AMPLIFY Phase III Study
September 7, 2017
Notice of Interim Results
August 24, 2017
Notification of Major Interest in Shares
June 29, 2017
Result of AGM 2017
May 26, 2017
Annual Report and Notice of Annual General Meeting
April 28, 2017
Non-Executive Director Retirements
April 25, 2017
Top-Line Results of House Dust Mite Allergy Study
April 18, 2017
Completion of Transaction and Admission to Trading
April 12, 2017
Early Termination of HSR Waiting Period Granted
April 11, 2017
Result of General Meeting on 3 April 2017
April 3, 2017
Publication of a Prospectus
March 17, 2017
Interim Results
September 27, 2016
BLOCK LISTING SIX MONTHLY RETURN
July 18, 2016
Top-Line Results from Cat Allergy Phase III Study
June 20, 2016
Grass Registration Study Initiation
May 25, 2016
Grant of awards to Directors
May 19, 2016
Posting of Annual Report and Notice of AGM
March 22, 2016
Full Year Results 2015
March 11, 2016
TR-1: Notification of Major Interest in Shares
January 8, 2016
Blocklisting Interim Review
December 31, 2015
Regulatory Approval
November 24, 2015
Business Update
October 27, 2015
Director Dealing
August 27, 2015
Aerocrine-Increased Acceptances In Offer Period
June 30, 2015
Completion of acquisition of Prosonix Limited
June 15, 2015
TR1 Notification of Major Interest in Shares
June 12, 2015
Notification Of Major Interest In Shares
June 11, 2015
Results of the placing and open offer
June 9, 2015
Director Dealing - Correction
May 29, 2015
Publication of Circular and Prospectus
May 18, 2015